Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular
Hideki Koizumi1, Tetsuya Yamagishi, Taizo Yamazaki
1Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. hidekoiz@koto.kpu-m.ac.jp
Insights
Polypoidal choroidal vasculopathy (PCV) with choroidal vascular hyperpermeability is linked to bilateral membranes and poor ranibizumab response. These patients often have a history of central serous chorioretinopathy (CSC).
Area of Science:
- Ophthalmology
- Medical Imaging
- Retinal Diseases
Background:
- Polypoidal choroidal vasculopathy (PCV) is a subtype of age-related macular degeneration.
- Choroidal vascular hyperpermeability is a key feature assessed via indocyanine green angiography (ICGA).
- Understanding PCV characteristics is crucial for effective treatment strategies.
Purpose of the Study:
- To determine the association between clinical features of PCV and choroidal vascular hyperpermeability.
- To evaluate the relationship between hyperpermeability and patient history, clinical signs, and treatment outcomes.
- To identify prognostic indicators in PCV patients.
Main Methods:
- Retrospective analysis of 89 PCV patients' medical records and ICGA findings.
- Evaluation of background factors, clinical manifestations, and response to intravitreal ranibizumab.
- Statistical analysis to identify significant relationships (P-values reported).
Main Results:
- Choroidal vascular hyperpermeability was present in 34.8% of PCV patients.
- Hyperpermeability correlated with bilateral neovascular membranes (P=.009) and prior central serous chorioretinopathy (CSC) (P=.01).
- Eyes with hyperpermeability showed increased subfoveal thickness (P < .001) and poorer response to ranibizumab (persistent fluid, P=.01).
Conclusions:
- PCV patients with choroidal vascular hyperpermeability exhibit more bilateral neovascularization and a history of CSC.
- These patients often present with thickened choroids and reduced treatment efficacy with ranibizumab.
- Choroidal vascular hyperpermeability is a significant indicator of disease severity and treatment resistance in PCV.
Purpose:
To investigate the relationship between the clinical characteristics of polypoidal choroidal vasculopathy (PCV) and choroidal vascular hyperpermeability seen on indocyanine green angiography.
Design:
Retrospective, consecutive, interventional case series.
Methods:
We reviewed the medical records and the angiograms of 89 patients with PCV. The relationship between choroidal vascular hyperpermeability and background factors, associated clinical manifestations, and treatment responses to intravitreal injections of ranibizumab were evaluated.
Results:
Of the 89 patients with PCV, 31 patients (34.8%) demonstrated choroidal vascular hyperpermeability. The patients with choroidal vascular hyperpermeability more frequently showed bilateral neovascular membrane than those without choroidal vascular hyperpermeability (P=.009) and had a significant relationship with a history of central serous chorioretinopathy (CSC) (P=.01). Of the 98 eyes with treatment-naïve PCV, 34 eyes with choroidal vascular hyperpermeability demonstrated significantly greater subfoveal thickness than the 64 eyes without choroidal vascular hyperpermeability (P < .001). However, no significant relationship was found between choroidal vascular hyperpermeability and the other biomicroscopic and angiographic phenotypes of PCV. Three monthly intravitreal injections of ranibizumab were performed on 57 patients with treatment-naïve PCV, and the presence of choroidal vascular hyperpermeability was significantly related to the persistent retinal fluid 1 month after the third ranibizumab injection (P=.01).
Conclusions:
The patients with PCV associated with choroidal vascular hyperpermeability more frequently demonstrated bilateral neovascular membrane, a history of CSC, a thickened choroid, and poor responses to intravitreal injections of ranibizumab than those without choroidal vascular hyperpermeability.
More Related Videos
05:14Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography
Published on: August 11, 2023
12:28Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
Related Concept Videos
Diabetic Retinopathy
Portal Hypertension
Glaucoma: Overview
